Mangrove Partners’s CERo Therapeutics Holdings, Inc. Warrants CEROW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-163,538
Closed -$1.78M 175
2023
Q2
$1.78M Hold
163,538
0.12% 143
2023
Q1
$1.75M Hold
163,538
0.11% 166
2022
Q4
$1.68M Hold
163,538
0.09% 227
2022
Q3
$1.65M Hold
163,538
0.1% 243
2022
Q2
$1.64M Hold
163,538
0.08% 346
2022
Q1
$1.64M Hold
163,538
0.09% 326
2021
Q4
$1.62M Buy
+163,538
New +$1.62M 0.1% 381